Papers - NISHIDA, Yoshihiro
-
Potential drug interactions between pazopanib and proton pump inhibitors/potassium-competitive acid blockers in patients with soft tissue sarcoma. Reviewed Open Access
Liang Y, Maeda O, Shimokata T, Yokota K, Koike H, Sakai T, Ikuta K, Urakawa H, Nishida Y, Akiyama M, Ando Y.
Int Cancer Conf J. Vol. 13 ( 1 ) page： 63 - 67 2023.11
-
Clinical Outcome in Patients With High-grade Soft-tissue Sarcoma Receiving Prosthetic Replacement After Tumor Resection of the Lower Extremities: Tokai Musculoskeletal Oncology Consortium Study. Reviewed
Nakamura T, Sakai T, Tsukushi S, Kimura H, Wasa J, Hosono K, Izubuchi Y, Kozawa E, Nagano A, Asanuma K, Sudo A, Nishida Y.
In Vivo. Vol. 37 ( 6 ) page： 2642 - 2647 2023.11
-
The current management of clear cell sarcoma. Reviewed
Ikuta K, Nishida Y, Imagama S, Tanaka K, Ozaki T.
Jpn J Clin Oncol. Vol. 53 ( 10 ) page： 899 - 904 2023.10
-
Clinical investigation for the mechanisms of anaphylactic symptoms in osteoarthritis patients after diclofenac etalhyaluronate administration. Reviewed
Nishida Y, Yagami A, Takada S, Muramatsu D, Nobuoka Y, Okayama Y.
Mod Rheumatol. Vol. 20 2023.10
-
Efficacy of rehabilitation initiated in the early phase after simultaneous deceased donor liver and kidney transplantation: A case report. Reviewed
Tanaka S, Mizuno Y, Nojiri S, Futamura D, Nagaya M, Nishida Y, Sano Y, Ishida S, Kato M, Kurata N, Jobara K, Fujimoto Y, Ogura Y.
Medicine (Baltimore). Vol. 102 ( 38 ) page： e35324 - e35324 2023.9
-
Physical function and mental health trajectories in COVID-19 patients following invasive mechanical ventilation: a prospective observational study. Reviewed
Yamamoto H, Tanaka S, Kasugai D, Shimizu M, Tsuchikawa Y, Hori Y, Fugane Y, Inoue T, Nagaya M, Omote N, Higashi M, Yamamoto T, Jingushi N, Numaguchi A, Goto Y, Nishida Y.
Sci Rep. Vol. 13 ( 1 ) page： 14529 - 14529 2023.9
-
Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo. Reviewed Open Access
Zhang J, Nishida Y, Koike H, Zhuo L, Ito K, Ikuta K, Sakai T, Imagama S.
Int J Mol Sci. Vol. 24 ( 15 ) page： 12422 - 12422 2023.8
-
In-Hospital Fall Risk Prediction by Objective Measurement of Lower Extremity Function in a High-Risk Population. Reviewed
Tanaka S, Imaizumi T, Morohashi A, Sato K, Shibata A, Fukuta A, Nakagawa R, Nagaya M, Nishida Y, Hara K, Katsuno M, Suzuki Y, Nagao Y.
J Am Med Dir Assoc. Vol. 23 2023.8
-
Association between National Institutes of Health Stroke Scale and Functional Independence Measure scores in patients with ischemic stroke from convalescent rehabilitation outcomes. Reviewed
Senda J, Ito K, Kotake T, Mizuno M, Kishimoto H, Yasui K, Nakagawa-Senda H, Katsuno M, Nishida Y, Sobue G.
Nagoya J Med Sci. Vol. 85 ( 3 ) page： 428 - 443 2023.8
-
整形外科医の手による骨・軟部腫瘍の医師主導治験への道 腱滑膜巨細胞腫に対するザルトプロフェンを用いた医師主導治験(REALIZE study)の立案と実施 Reviewed
武内 章彦, 遠藤 誠, 川井 章, 西田 佳弘, 寺内 竜, 松峯 昭彦, 相羽 久輝, 中村 知樹, 尾崎 敏文, 星 学, 土屋 弘行
日本整形外科学会雑誌 Vol. 97 ( 8 ) page： S1557 - S1557 2023.8
-
Hand Grip Strength Assessment Based on Sarcopenia Diagnostic Criteria Predicts Swallowing Function. Reviewed
Okada T, Yamaguchi H, Tanaka S, Koyama K, Hishida A, Konno S, Nakamura M, Sugiura H, Nishida Y.
Dysphagia. 2023.7
-
A phase 1 trial of NY-ESO-1-specific TCR-engineered T-cell therapy combined with a lymph node-targeting nanoparticulate peptide vaccine for the treatment of advanced soft tissue sarcoma. Reviewed
Ishihara M, Nishida Y, Kitano S, Kawai A, Muraoka D, Momose F, Harada N, Miyahara Y, Seo N, Hattori H, Takada K, Emori M, Kakunaga S, Endo M, Matsumoto Y, Sasada T, Sato E, Yamada T, Matsumine A, Nagata Y, Watanabe T, Kageyama S, Shiku H.
Int J Cancer. Vol. 152 ( 12 ) page： 2554 - 2566 2023.6
-
叢状神経線維腫に対するMEK阻害剤セルメチニブの期待と注意事項 Reviewed
西田 佳弘, 野々部 典枝, 城所 博之, 加藤 太一, 武市 拓也, 生田 国大, 今釜 史郎
日本整形外科学会雑誌 Vol. 97 ( 6 ) page： S1427 - S1427 2023.6
-
叢状神経線維腫に対するMEK阻害剤セルメチニブの期待と注意事項 Reviewed
西田 佳弘, 野々部 典枝, 城所 博之, 加藤 太一, 武市 拓也, 生田 国大, 今釜 史郎
日本整形外科学会雑誌 Vol. 97 ( 6 ) page： S1427 - S1427 2023.6
-
Selumetinib in Japanese pediatric patients with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas: An open-label, phase I study. Reviewed
Suenobu S, Terashima K, Akiyama M, Oguri T, Watanabe A, Sugeno M, Higashimori M, So K, Nishida Y.
Neurooncol Adv. Vol. 5 ( 1 ) 2023.5
-
Significance of expression of CD109 in osteosarcoma and its involvement in tumor progression via BMP signaling. Reviewed Open Access
Mori N, Esaki N, Shimoyama Y, Shiraki Y, Asai N, Sakai T, Nishida Y, Takahashi M, Enomoto A, Mii S.
Pathol Res Pract. Vol. 245 page： 154443 - 154443 2023.5
-
Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer. Reviewed Open Access
Nakajima H, Yamaguchi J, Takami H, Hayashi M, Kodera Y, Nishida Y, Watanabe N, Onoe S, Mizuno T, Yokoyama Y, Ebata T.
Int J Clin Oncol. Vol. 28 ( 5 ) page： 688 - 697 2023.5
-
膝関節に発生した樹枝状脂肪腫に対して人工関節置換術を施工した1症例 Reviewed
高橋 裕, 藤林 孝義, 柘植 峻, 大倉 俊昭, 西田 佳弘
中部日本整形外科災害外科学会雑誌 Vol. 66 ( 3 ) page： 475 - 476 2023.5
-
Genomic patterns of malignant peripheral nerve sheath tumor (MPNST) evolution correlate with clinical outcome and are detectable in cell-free DNA. Reviewed
Cortes-Ciriano I, Steele CD, Piculell K, Al-Ibraheemi A, Eulo V, Bui MM, Chatzipli A, Dickson BC, Borcherding DC, Feber A, Galor A, Hart J, Jones KB, Jordan JT, Kim RH, Lindsay D, Miller C, Nishida Y, Proszek PZ, Serrano J, Sundby RT, Szymanski JJ, Ullrich NJ, Viskochil D, Wang X, Snuderl M, Park PJ, Flanagan AM, Hirbe AC, Pillay N, Miller DT.
Cancer Discov. Vol. 13 ( 3 ) page： 654 - 671 2023.3
-
Clinical results of active surveillance for extra-abdominal desmoid-type fibromatosis. Reviewed
Sakai T, Nishida Y, Ito K, Ikuta K, Urakawa H, Koike H, Imagama S.
Cancer Med. Vol. 12 ( 5 ) page： 5245 - 5254 2023.3